FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 9 analysts with an average price target of $14.97. This is a potential upside of $5.17 (52.76%) from yesterday's end of day stock price of $9.8.

Amicus Therapeutics's activity chart (see below) currently has 95 price targets and 81 ratings on display. The stock rating distribution of FOLD is 84.21% BUY and 15.79% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.75% with an average time for these price targets to be met of 403.43 days.

Highest price target for FOLD is $21, Lowest price target is $12, average price target is $14.97.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 13-Dec-2024.

Currently out of the existing stock ratings of FOLD, 16 are a BUY (84.21%), 3 are a HOLD (15.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$2.62 (27.93%)

$25

7 days ago
(13-Dec-2024)

6/8 (75%)

$2.62 (27.93%)

315

Buy

$17

$7.62 (81.24%)

$16

1 months 8 days ago
(12-Nov-2024)

6/15 (40%)

$6.47 (61.44%)

454

Buy

$21

$11.62 (123.88%)

$20

1 months 13 days ago
(07-Nov-2024)

0/6 (0%)

$10.07 (92.13%)

Buy

$15

$5.62 (59.91%)

$13

2 months 3 days ago
(17-Oct-2024)

2/8 (25%)

$3.03 (25.31%)

578

Buy

$18

$8.62 (91.90%)

$16

3 months 14 days ago
(06-Sep-2024)

2/5 (40%)

$6.31 (53.98%)

371

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 403.43 days on average for the stock forecasts to be realized with a an average price target met ratio 53.75

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Elemer Piros works at BENCHMARK and has 7 price targets and 8 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Kristen Kluska with highest potential upside - $11.62

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?